BlackRock Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$164K Buy
12,582
+1,237
+11% +$16.1K ﹤0.01% 2704
2016
Q3
$196K Buy
11,345
+529
+5% +$9.14K ﹤0.01% 2620
2016
Q2
$195K Buy
10,816
+897
+9% +$16.2K ﹤0.01% 2581
2016
Q1
$188K Buy
9,919
+6,301
+174% +$119K ﹤0.01% 2577
2015
Q4
$97K Sell
3,618
-11,382
-76% -$305K ﹤0.01% 2680
2015
Q3
$366K Buy
+15,000
New +$366K ﹤0.01% 2309